MImAbs will be attending SITC's 39th annual meeting on November 6-10, 2024, in Houston, USA!

We invite you to meet our team members Nathalie Joly and Manuel PELE at Booth No. 1042

As a CRO specializing in antibody/ADC generation, we ensure seamless preclinical development and transfer to clinical phases with expert support.

Join us to discover our innovative solutions and discuss potential collaborations.

#SITC24 #SITC2024 #Immunotherapy #CancerResearch #Immunotherapies #oncology #Biotech #MImAbs